Benzinga | Aug 5, 2021 08:04AM EDT

Insmed Q2 EPS $(1.07) Misses $(0.85) Estimate, Sales $45.40M Beat $43.72M Estimate

Insmed (NASDAQ:INSM) reported quarterly losses of $(1.07) per share which missed the analyst consensus estimate of $(0.85) by 25.88 percent. This is a 67.19 percent decrease over losses of $(0.64) per share from the same period last year. The company reported quarterly sales of $45.40 million which beat the analyst consensus estimate of $43.72 million by 3.84 percent. This is a 6.84 percent increase over sales of $42.49 million the same period last year.